News

WebMD20h
FDA Approves New Treatment for Dry Eye Disease
The FDA has approved Tryptyr (acoltremon) as the first TRPM8-targeting eye drop for dry eye disease, stimulating natural tear ...
Transparency Market Research2d
Retinal Drugs Market
Retinal drugs market growth driven by aging population, rising AMD prevalence, and advances in ophthalmic drug delivery and retinal disease treatment innovation.
C&EN2d
Alzheimer’s Disease Is Responsible for Progressive Age-Dependent Differential Expression of Various Protein Cascades in Retina of Mice
College of Life Sciences and Oceanography, Shenzhen University, Shenzhen 518060, P. R. China ...
Ocugen's Retina Gene Therapy Drug Gets Rare Disease Designation From FDA
Ocugen's drug to treat retina diseases received a rare pediatric disease designation from U.S. regulators. The biotechnology said Tuesday that the Food and Drug Administration granted the designation ...
SciELO7d
Chronic kidney disease and retinal manifestations and repercussions
The objective of this study was to report a case of bilateral hypertensive retinopathy in a female child with chronic renal disease caused by focal segmental ... Fundoscopic examination showed ...
Ophthalmology Times8d
Q&A: Tarek Hassan, MD, on a new retinotomy technique
Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...
NC Biotech10d
FDA grants RMAT designation to Atsena’s gene therapy for rare eye disease
Durham-based Atsena Therapeutics has received Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration (FDA) for ATSN-201, its gene therapy product for the ...
bjo.bmj10d
Evaluation of a self-imaging OCT for remote diagnosis and monitoring of retinal diseases
except in the cases of retinal detachment (κ=0.5). All eyes (100%) in the selected cohort and 242 eyes (76.8%) in the consecutive cohort successfully completed self-imaging. Participants spent less ...
Newseria BIZNES11d
Retinal Detachment Market Analysis: Key Trends, Share, Growth Drivers, And Forecast 2025-2034
It will grow to $2.98 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. ” — The Business Research Company LONDON, GREATER LONDON, UNITED KINGDOM, May 28, 2025 /EINPresswire.com/ -- The ...
Fierce Biotech12d
Atsena eye disease gene therapy hits safety goals, closes retinal splits in phase 1/2
Hot on the heels of a $150 million fundraise, Atsena Therapeutics is back with early-stage data for the company’s eye disease ...
BMJ16d
Retinal image-based deep learning for mild cognitive impairment detection in coronary artery disease population
In addition, our study excluded retinal photographs from patients with accompanying eye diseases and age-related eye diseases (eg, age-related macular degeneration and glaucoma) that are common in ...
IEEE18d
Classification of Retinal Diseases Using Transfer Learning Approach
Abstract: Retinal disease classification of Color Fundus Images using Computational Imaging has been widely accepted. This paper proposes a transfer learning approach for Retinal Disease ...